| Title |
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
|
|---|---|
| Published in |
Investigational New Drugs, June 2014
|
| DOI | 10.1007/s10637-014-0120-7 |
| Pubmed ID | |
| Authors |
Lawrence M. Gelbert, Shufen Cai, Xi Lin, Concepcion Sanchez-Martinez, Miriam del Prado, Maria Jose Lallena, Raquel Torres, Rose T. Ajamie, Graham N. Wishart, Robert Steven Flack, Blake Lee Neubauer, Jamie Young, Edward M. Chan, Philip Iversen, Damien Cronier, Emiko Kreklau, Alfonso de Dios |
Mendeley readers
The data shown below were compiled from readership statistics for 254 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Japan | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 250 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 45 | 18% |
| Researcher | 38 | 15% |
| Student > Bachelor | 29 | 11% |
| Student > Master | 21 | 8% |
| Other | 13 | 5% |
| Other | 28 | 11% |
| Unknown | 80 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 52 | 20% |
| Medicine and Dentistry | 44 | 17% |
| Agricultural and Biological Sciences | 24 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 7% |
| Chemistry | 18 | 7% |
| Other | 21 | 8% |
| Unknown | 76 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2024.
All research outputs
#1,163,667
of 25,861,751 outputs
Outputs from Investigational New Drugs
#20
of 1,266 outputs
Outputs of similar age
#11,033
of 244,474 outputs
Outputs of similar age from Investigational New Drugs
#2
of 14 outputs
Altmetric has tracked 25,861,751 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,266 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,474 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.